Japanese Pharmacology & Therapeutics（JPT）
Vol. 26 No. 12 1998
* With abstract in English
Thirteen-week oral toxicity study followed by five-week recovery study of TU-199 in rats
T. Morohashi, et al.
Jpn Pharmacol Ther 1998 26(12) 1897-922*
Thirteen-week oral toxicity study followed by five-week recovery study of TU-199 in beagle dogs
M. Okamoto, et al.
Jpn Pharmacol Ther 1998 26(12) 1923-49*
Teratological study by oral administration of TU-199 in rats
S. Ishida, et al.
Jpn Pharmacol Ther 1998 26(12) 1951-68*
Teratological study by oral administration of TU-199 in rabbits
T. Umemura, et al.
Jpn Pharmacol Ther 1998 26(12) 1969-78*
Mutagenicity study on TU-199
H. Daigo, et al.
Jpn Pharmacol Ther 1998 26(12) 1979-92*
Pharmacokinetic studies of TU-199 (I)
―Absorption, distribution and excretion after single administration to rats and dogs―
Y. Esumi, et al.
Jpn Pharmacol Ther 1998 26(12) 1993-2005
Pharmacokinetic studies of TU-199 (II)
―Absorption, distribution and excretion after multiple administration to rats and transfer into fetus and milk―
Y. Esumi, et al.
Jpn Pharmacol Ther 1998 26(12) 2007-16
Pharmacokinetic studies of TU-199 (III)
―Metabolism in rats and dogs―
S. Kurosawa, et al.
Jpn Pharmacol Ther 1998 26(12) 2017-32
Inhibitory effects of histamine-added mouse γ-globulin,neurotropin and dexamethasone on eosinophil accumulation induced by ragweed pollen in BALB/c mice
Y. Yamazaki, et al.
Jpn Pharmacol Ther 1998 26(12) 2033-40
Effect of a long period administration of voglibose on glucose and lipoprotein metabolisms in patients with non-insulin dependent diabetes mellitus (NIDDM) accompanied by hyperlipidemia
K. Hayashi, et al.
Jpn Pharmacol Ther 1998 26(12) 2041-6*
Clinical study of an improved formulation of EPADEL CAPSULE 300 (MND-21S) in hyperlipidemic patients
Y. Saito, et al.
Jpn Pharmacol Ther 1998 26(12) 2047-62
Clinical application of poly-L-leucine for the split thickness skin graft donor site
S. Kyutoku, et al.
Jpn Pharmacol Ther 1998 26(12) 2063-7*